首页 | 本学科首页   官方微博 | 高级检索  
     


Secukinumab is effective in treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and safety from the PROSPECT study
Authors:D. Thaçi  A. Körber  R. von Kiedrowski  T. Bachhuber  N. Melzer  T. Kasparek  E. Duetting  G. Kraehn-Senftleben  U. Amon  M. Augustin
Affiliation:1. Comprehensive Centre of Inflammation Medicine, University of Lübeck, Lübeck, Germany;2. Department of Dermatology, University Hospital Essen, Essen, Germany;3. Dermatologische Spezialpraxis, Selters, Germany;4. Novartis Pharma GmbH, Nürnberg, Germany;5. Hautzentrum Donau Alb, Blaubeuren, Germany;6. International Centre for Skin Disease DermAllegra, Hohenstadt/Nürnberg, Germany;7. Institute for Health Services Research in Dermatology and Nursing (IVDP), German Centre for Health Services Research in Dermatology (CVderm), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号